Particular features of clinical manifestations of the gonococcal infection and tactics for treating the disease in view of the antibiotic sensitivity of N. gonorrhoeae in the Arkhangelsk region

Cover Page

Abstract


Goal of the study. To examine clinical manifestations of the gonococcal infection and determine the tactics for treating the disease in view of the antibiotic sensitivity of N. gonorrhoeae strains obtained from patients suffering from the gonococcal infection in the Arkhangelsk region. Study materials. Patients suffering from the gonococcal infection (14,502 male and 4,135 female patients); 254 N. gonorrhoeae strains obtained from patients suffering from the gonococcal infection in the Arkhangelsk region in 2006-2013. Study methods: examination of the case history, clinical, instrumental (ultrasound examination) and laboratory (microscopy, bacteriological). The sensitivity of N. gonorrhoeae to antimicrobial drugs (penicillin, tetracycline, ciprofloxacin, spectinomycin, azithromycin and ceftriaxone) was studied by the agar serial dilution method. Key findings. Non-complicated forms of the disease prevailed in patients suffering from the gonococcal infection who consulted medical dermatovenereology institutions in the Arkhangelsk region for examination and treatment (98.3%), and the course of the inflammatory process was asymptomatic (10.3%) or with few symptoms (55.8%). A high level of N. gonorrhoeae resistance to penicillin, tetracycline, ciprofloxacin, spectinomycin and azithromycin was revealed in 2006-2011. The exclusion of these drugs from the treatment regimens for the gonococcal infection made it possible to substantially reduce the resistance level in 2013. Ceftriaxone was the only drug for the treatment of the gonococcal infection that remained efficient for the treatment of all N. gonorrhoeae strains during the study period. Conclusion. A complex of measures to prevent the propagation of the gonococcal infection in the Arkhangelsk region must include screenings of risk groups with regard to the infection and propagation of the disease regardless of the presence of clinical symptoms of the inflammatory process, introduction of high-sensitivity and specific molecular and biological diagnostics methods, and administration of an anti-gonococcal therapy in view of the antibiotic resistance of N. gonorrhoeae strains obtained from patients in the region.

M. R. Rakhmatulina

State research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation

Author for correspondence.
Email: rahmatulina@cnikvi.ru

Russian Federation

K. V. Baryshkov

Arkhangelsk Clinical Dermatovenerology Dispensary

Email: noemail@neicon.ru

Russian Federation

N. K. Abuduev

State research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation

Email: noemail@neicon.ru

Russian Federation

  1. Bignell C., Fitzgerald M. BASHH Guideline Development Group. UK national guideline for the management of gonorrhoeae in adults, 2011. Int J STD AIDS 2011; 22: 541-7.
  2. Centers for Disease Control and Prevention (CDC). Sexually Transmitted Diseases Treatment Guidelines 2010. MMWR 2010; 59 (No. RR-12): 49-55. Литература
  3. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2010. Atlanta, Ga.: U.S. Department of Health and Human Services; 2011.
  4. Кубанова А.А., Мелехина Л.Е., Кубанов А.А., Богданова Е.В. Ресурсы и деятельность медицинских организаций дерматовенерологического профиля в Российской Федерации в 2013 г. Вестн дерматол венерол 2014; (3): 16-36
  5. Бутов Ю.С., Скрипкин Ю.К., Иванов О.Л. Дерматовенерология. Национальное руководство. Краткое издание М: ГЭОТАР-Медиа, 2013
  6. Клинические рекомендации по ведению больных инфекциями, передаваемыми половым путем, и урогенитальными инфекциями. М: ДЭКС-ПрЕСс, 2012
  7. Приказ Минздрава РФ от 20.08.2003 № 415 «Об утверждении протокола ведения больных "Гонококковая инфекция”»
  8. Hook E.W., Handsfield H.H. Gonococcal infections in the adult. In Holmes KK, Sparling PF, et al. (eds.). Sexually Transmitted Diseases 4th ed. New York, NY. McGraw Hill 2008; 627-45.
  9. Diagnosis and Management of Gonococcal Infections Mejebi T. Mayor, MD, JD, Providence Hospital, Washington, District of Columbia Michelle A. Roett, MD, MPH, Georgetown University/Providence Hospital Family Medicine Residency Program, Colmar Manor, Maryland Kelechi A. Uduhiri, MD, MPH, MS American Family Physician www.aafp.org/afp 2012; (Nov 15); 86 (10): 931-938.
  10. Bignell C., Unemo M. 2012 European Guideline on the Diagnosis and Treatment of Gonorrhoea in Adults. http://www.iusti.org/regions/Europe/ pdf/2012/Gonorrhoea_2012.pdf
  11. Sherrard J., Barlow D. Gonorrhoea in men: clinical and diagnostic aspects. Genitourin Med 1996; 72: 422-6.
  12. World Health Organization (WHO), Department of Reproductive Health and Research: Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. Geneva: WHO; 2012: 1-36.
  13. Tapsall J.W., Ndowa F., Lewis D.A., Unemo M. Meeting the public health challenge of multidrug-and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther2009; 7: 821-34.
  14. European Centre for Disease Prevention and Control (ECDC). Gonococcal antimicrobial susceptibility surveillance in Europe 2010. Stockholm: ECDC 2012. (http://ecdc.europa.eu/en/ publications/Publications/1206-Gonococcal-AMR.pdf) (accessed 30 October 2012).
  15. Taylor S.N., DiCarlo R.P., Martin D.H. Comparison of methylene blue/gentian violet stain to Gram’s stain for the rapid diagnosis of gonococcal urethritis in men. Sex Trans Dis 2011; 38: 995-6.

Views

Abstract - 41

PDF (Russian) - 13

Refbacks

  • There are currently no refbacks.

Copyright (c)



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies